ストックスクリーナーアプリを入手
10.66
0.00%
0.00
アフターアワーズ：
10.66
前日終値:
$10.66
開ける：
$10.65
24時間の取引高:
225.39K
Relative Volume:
1.95
時価総額：
$258.79M
収益：
-
当期純損益:
$6.66M
株価収益率:
53.78
EPS:
0.1982
ネットキャッシュフロー:
$-379.20K
1週間 パフォーマンス:
+0.19%
1か月 パフォーマンス:
+0.38%
6か月 パフォーマンス:
+2.70%
1年 パフォーマンス:
+4.10%
1日の値動き範囲:
$10.65
$10.66
1週間の範囲:
$10.63
$10.66
52週間の値動き範囲:
$10.17
$10.66
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
名前
Drugs Made In America Acquisition Corp
セクター
電話
646-726-7074
住所
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, CCXI, DMII
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.66 | 258.79M | 0 | 6.66M | -379.20K | 0.1982 |
LION
Lionsgate Studios Corp
|
13.58 | 4.05B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.24 | 1.91B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
20.62 | 958.27M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
15.26 | 883.40M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.10 | 643.05M | 0 | 8.58M | -1.11M | 0.134 |
Drugs Made In America Acquisition Corp (DMAA) 最新ニュース
Enterprise value to EBITDA forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
OACCU Stock Fund Price and Chart — NASDAQ:OACCU - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
Pfizer Inc. - Encyclopedia Britannica
NTWO PE Ratio & Valuation, Is NTWO Overvalued - Intellectia AI
Drugs Made In America Acquisition Corp. (DMAA) Holds Steady Near Support as SPAC Sector WatchesHedge Fund Exposure - dars.gov.et
DMAADrugs Made In America Acquisition Corp Volatility & Greeks - Finviz
DMII Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Price to book forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
Price to sales forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
Feis Equities and Lawrence Feis disclose 5.08% ownership in DMAA (DMAA) - Stock Titan
Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView
Drugs Made In America Acquisition II Units (DMIIU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
QLEP Stock Price and Chart — NYSE:QLEP - TradingView
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 - TradingKey
Drugs Made In America Acquisition Corp. (DMAA) Holds Steady Near Resistance as SPAC Sentiment Remains CautiousHedge Fund Exposure - dars.gov.et
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIU - TradingView
Drugs Made In America Acquisition II Corp. Rights (DMIIR) Holds Flat at $0.10 Amid Low ActivityGrowth Factor - dars.gov.et
Drugs Made In America Acquisition Corp (DMAAU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PLMK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Drugs Made In America Acquisition Corp (DMAAR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAAU) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition Corp (DMAAR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Units - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition II Units (DMIIU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Ord Shs - TradingKey
Drugs Made In America Acquisition Corp (DMAA) 財務データ
収益
当期純利益
現金流量
EPS
0.17%
0.00%
大文字化:
|
ボリューム (24 時間):